Prevalence and predictive factors of cancer pain
DOI:
https://doi.org/10.51481/amc.v44i4.430Keywords:
dolor canceroso , cáncer , prevalencia , epidemiologíaAbstract
Cancer pain is recognized as a public health problem world- wide, and frequently affects the quality of life of cancer patients. Its prevalence and severity varies according to the primary site, the stage of the disease, the adequacy of the analgesics prescribed, and some socio-demographic vari- ables. Knowledge of the epidemiology of cancer pain is essential to establish priorities on cancer pain and palliative care policies. A review of the literature on the prevalence and predictive factors of cancer pain is presentedDownloads
References
World Health Organization. Cancer Pain Relief and Palliative Care:report of a expert committee. Génova: World Health Organisation,1990.
Schug SA, Zech D, Dorr U. Cancer pain management according toWHO analgesic guidelines. J Pain Symptom Manage 1990; 5(1):27-32.
Franks PJ, Salisbury C, Bosanquet N, Wilkinson EK, Lorentzon M,Kite S et al. The level of need for palliative care: a systematic reviewof the literature. Palliat Med 2000; 14(2):93-104
Foley KM. Pain syndromes in patients with cancer. En: Bonica JJ et al,eds. Advances in pain research and therapy: International symposiumon pain in advanced cancer. New York: Raven Press, 1979:59-75.
Spiegel D, Bloom JR. Pain in metastatic breast cancer. Cancer 1983;52:341-345.
Peteet J, Tay V, Cohen G, MacIntyre J.. Pain characteristics and treat-ment in an outpatient cancer population. Cancer 1986; 57:1259-1265.
Greenwald HP, Bonica JJ, Bergner M. The prevalence of pain in fourcancers. Cancer 1987; 60:2563-2569.
Portenoy RK, Miransky J, Thaler HT, Hornung J, Bianchi C, Cibas-Kong I et al. Pain in ambulatory patients with lung or colon cancer.Cancer 1992; 70(6):1616-1624.
Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, StewartJAet al. Pain and its treatment in out patients with metastatic cancer. NEngl J Med 1994; 330:592-596.
Larue F, Colleau SM, Brasseur L, Cleeland CS. Multicentre study ofcancer pain and its treatment in France. BMJ 1995; 310:1034-1037.
Daut RL, Cleeland CS. The prevalence and severity of pain in cancer.Cancer 1982; 50:1913-1918.
Vainio A, Auvinen A. Prevalence of symptoms among patients withadvanced cancer: aninternationalcollaborative study. SymptomPrevalence Group. J Pain Symptom Manage 1996; 12(1):3-10.
Beck SL, Falkson G. Prevalence and management of cancer pain inSouth Africa. Pain 2001; 94:75-84.
Foley KM. Management of pain of malignant origin. En: Tyler HR,Dawson PM, eds. Current Neurology, vol. 2. Boston: HoughtonMifflin, 1979:279.
Higginson IJ, Eran J. A multicenter evaluation of cancer pain control bypalliative care teams. J Pain Symptom Manage 1997; 14(1):29-35.Dolor por cáncer/ Rojas J. y Salas I.
AMC, octubre-diciembre 2002, vol 44 (4)
McCarthy EP, et al. Dying with cancer: patients' function, symptoms,and care preferences as death approaches. J Am Geriatr Soc 2000; 48(5Suppl):S110-S121.
Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ. Pain and treat-ment of pain in minority patients with cancer. Ann Intern Med 1997;127:813-816.
Anderson KO, Mendoza TR, Valero V, Richman SP, Russell C, HurleyJ et al. Minority cancer patients and their providers: pain managementattitudes and practice. Cancer 2000; 88(8):1929-1938.
Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R etal. Management of pain in elderly patients with cancer. JAMA 1998;279(23):1877-1882.
Andersen G, Sjogren P. Epidemiology of cancer pain. Ugeskr Laeger1998; 160(18): 2681-2684.
Zeppetella G, O' Doherty CA, Collins S. Prevalence and characteristicsof breakthrough pain in cancer patients admitted to a hospice. J PainSymptom Manage 2000; 20(2):87-92.
Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern ofsymptoms in patients with cancer pain: a prospective evaluation of1635 cancer patients referred to a pain clinic. J Pain Symptom Manage1994; 9(6):372-382.
Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S.Symptoms during cancer pain treatment following WHO-guidelines: alongitudinal follow up study of symptom prevalence, severity and eti-ology. Pain 2001; 93:247-257.
Dobratz MC, Burns KM, Oden RV. Pain in home hospice patients: anexploratory descriptive study. Hosp J 1989; 5(3-4):117-133.
Ger LP, Ho ST, Wang JJ, Cherng CH. The prevalence and severity ofcancer pain: a study of newly-diagnosed cancer patients in Taiwan. JPain Symptom Manage 1998; 15(5):285-293.
Wells N. Pain intensity and pain interference in hospitalized patientswith cancer. Oncol Nurs Forum 2000; 27(6):985-991.
Gordon C. The effect of cancer pain on quality of life in different eth-nic groups: a literature review. Nurse Pract Forum 1997; 8(1): 5-13.
Sterlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS.When is cancer pain mild, moderate or severe? Grading pain severityby its interference with function. Pain 1995; 61:277-284.
Ministerio de Salud. Incidencia y mortalidad por tumores malignos.San José: Ministerio de Salud, 1996.
Stjernsward J. WHO cancer pain relief programme. Cancer Surv 1988;7(1):195-208.
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
